SCHEMBL10014820

COC(=O)[C@H]1O[C@@H](OC2[C@@H](COS(=O)(=O)OC)O[C@H](O[C@H]3[C@H](OC)[C@@H](OC)[C@H](O[C@H]4[C@H](OS(=O)(=O)OC)[C@@H](OS(=O)(=O)OC)[C@@H](OC)O[C@@H]4COS(=O)(=O)OC)O[C@H]3C(=O)OC)[C@H](OS(=O)(=O)OC)[C@H]2OS(=O)(=O)OC)[C@H](OC)[C@@H](OC)[C@@H]1O[C@H]1O[C@H](COS(=O)(=O)OC)C(OCCOCCOCCOCCCC(=O)CSC(C)(C)C)[C@H](OC)[C@H]1OC

nearest known ligand 0.46

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	SERPINC1	P01008	3/20	0.46

▸	F10	P00742	4/20	0.41

▸	F2	P00734	1/20	0.41

▸	FGF1	P05230	7/20	0.40

▸	HPSE	Q9Y251	10/20	0.36

▸	FGF2	P09038	4/20	0.34

▸	VEGFA	P15692	1/20	0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL10014812	1.00	SERPINC1 (0.46)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014427	0.93	SERPINC1 (0.43)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014807	0.93	SERPINC1 (0.43)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014819	0.93	SERPINC1 (0.43)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014821	0.93	SERPINC1 (0.43)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014413	0.91	SERPINC1 (0.42)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014804	0.91	SERPINC1 (0.42)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014801	0.91	SERPINC1 (0.46)	SERPINC1F10F2FGF1HPSE
SCHEMBL15893508	0.86	SERPINC1 (0.51)	SERPINC1F10F2FGF1HPSE
SCHEMBL10014815	0.85	SERPINC1 (0.50)	SERPINC1F10F2FGF1HPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20120039843-A1	CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE	N.V. ORGANON (NL)	2012-02-16	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20120039843-A1	CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE	SERPINC1, SELP, F13B	SERPINC1 1/4885F10 106/4885F2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.